Blog

Renub Research, Roswell, GA

According to Renub Research report titled, “Canada Fast Food Market, Share, Insight, Forecast 2022-2027, Industry Trends, Growth, Size, Impact of COVID-19, Company Analysis” Canada Fast Food Market Size was USD 31.8 Billion in 2021. The Canadian food industry has evolved and changed to meet customer demands and consumer behavior. Remarkably, food is prepared and served at independent fast-food restaurants, street vendors, or chained fast-food restaurants such as Tim Hortons, Starbucks, McDonald's, Dairy Queen, KFC, Dominoes, Pizza Hut, Wendy's, and Burger King is referred to as fast food.

 

Besides, they can be used as a substitute for home-cooked meals. According to BC Food Web, fast food accounted for 6.3 percent of the average Canadian's daily food intake in 2020. As a result, fast food has established roots in both developed and developing economies over time, and it is primarily accepted due to its quick availability and taste factor.

 

COVID-19's Impact on the Canadian Fast Food Industry:

The COVID-19 pandemic harmed Canada's fast-food industry due to increased cases and fears of infection from food. Furthermore, revenue has been impacted by operational disruptions in the hotel and food & beverage industries and disturbances in the supply chain provoked by the COVID-19 outbreak. During the pandemic, increased awareness of the benefits of eating healthy foods influenced market growth. Regardless, due to an increase in the number of fast-food franchises and growing demand for online food deliveries, the market regained its demand following the pandemic.

 

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=canada-fast-food-market-p.php

 

Canada Fast Food Industry Is Anticipated to Expand At A CAGR Of 4.7% From 2021-2027:

The major factors propelling the market expansion are increased consumer spending and the growing influence of food delivery applications. Furthermore, faster urbanization and globalization are attributed to the increase in restaurants and hotels, which is expected to boost the Canadian fast-food market's growth. Again, because women do not have enough time to prepare meals, they turn to fast food and use technology to order, which fuels the development of the Canadian fast-food market. Additionally, increased media and travel exposure to international cuisine will continue to drive the growth of this market.

 

Burgers/Sandwiches and Pizza Are the Most Favored Fast Food in Canada:

Depending on the type, the market revolves around pizza/pasta, burgers/sandwiches, chicken, Asian/Latin American food, and seafood. Due to the flavors and ingredients used in the products, burgers/sandwiches have been the most popular fast food among consumers. The vast availability of burger options, including products with protein options such as venison, beef, and several others, can be attributed to the growing demand for burgers/sandwiches.

 

Furthermore, several food-service operators experimented with various cheese, bacon, onion, meatloaf, and other fillings. Nonetheless, pizza/pasta is the most popular fast food in Canada, owing to increased consumer demand for taste and preferences, and pizza is the most popular takeout and delivery option. During the Canadian fast-food market forecast, it is expected to grow at a phenomenal rate.

 

Service That Is Quick Restaurants Are the Most Popular Medium Among Canadians:

As per our analysis, in Canada, the Fast Food Market, the end-user industries such as Quick Service Restaurants (QSRs), Street Vendors, Home Delivery, Cafés, and Bars, among others, use fast food extensively. Consumers in Canada prefer quick-service restaurants, driving up demand for fresh, tasty, and appealing food at a reasonable price. As a result, the demand for quick-service restaurants is growing. Besides, during the pandemic, the home delivery option has seen a lot of growth. Wherein, the plurality of consumers chooses to order online while staying indoors.

 

Competitive Landscape:

In our report, Starbucks Corp, Domino's Pizza Inc, The Wendys Co., Kentucky Fried Chicken (KFC), Tim Hortons, Restaurant Brands International Inc, A&W Food Services of Canada Inc, MTY Food Group Inc, Papa John's International Inc, Performance Food Group Company are all analyzed to be strong players in the Canada Fast Food Market. The market's major players have extensive global distribution networks. Furthermore, businesses are improving their menus and services in response to shifting consumer preferences. Moreover, an increase in the number of quick-service restaurants in the industry is aiding sales.

 

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/canada-fast-food-market-p.php

 

Market Summary:

• Type: We have covered Independent Consumer, Chained Consumer in our market analysis.
• Cuisines Type: In our report we have studied the market for Pizza/Pasta, Burgers/Sandwiches, Chicken, Asian/Latin American food, and seafood
• End User: We have covered Quick Service Restaurant (QSR), Street Vendors, Home Delivery, Cafés, and bars and other as market for end-users in Canada Fast Food Market.
• Company Analysis: The key players covered are Starbucks Corp, Domino's Pizza Inc, The Wendys Co., Kentucky Fried Chicken (KFC), Tim Hortons, Restaurant Brands International Inc, A&W Food Services of Canada Inc, MTY Food Group Inc, Papa John's International Inc, Performance Food Group Company

 

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

 

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

As per the latest report by Renub Research titled "United States Anesthesia Drugs Market, Size, Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis" United States Anesthesia Drugs Market Size was US$ 4.9 Billion by 2027. In the United States, anesthesia drug is one of the milestones in the pharmaceutical industry, which benefits patients with painless treatment and impossible to perform surgery. The US is home to bigwigs in the pharmaceutical sector to increase their stakes in the United States market. Anesthesia meant the condition of holding sensation blocked or temporarily taken away. This authorizes the patient to undergo surgery and other procedures without distress and pain they would otherwise experience. Anesthesia drugs are used while performing surgical procedures to control pain, heart rate, blood pressure, breathing, rhythm, and blood flow.

 

Top Impacting Factors:

Notwithstanding, the United States anesthesia drug market is driven by the rising number of surgeries, the growing aging population with increasing chronic conditions, and advancements in anesthesia technologies. As per the statistics provided by the (ASPS) American Society of Plastic Surgeons, in 2019, nearly 16.3 Million cosmetic minimally-invasive procedures and 1.8 Million cosmetic surgical were performed in the United States.

 

Request a Free Sample Copy of the Report:  https://www.renub.com/request-sample-page.php?gturl=united-states-anesthesia-drugs-market-and-forecast-31-p.php

 

Furthermore, the demand for various anesthetics goes hand-in-hand with the performed surgical procedures. The application of anesthetics in general surgeries is anticipated to contribute significantly to the market's growth in the United States. Further, new anesthesia drugs are being developed, which is predicted to propel market growth. For instance, in 2020, Medova and the New York School of Regional Anesthesia (NYSORA) entered a partnership to introduce SAFIRA (SAFer Injection for Regional Anesthesia) in the United States.

 

COVID-19 Impact on Anesthesia Drugs Industry:

In the United States, the demand for anesthesia drugs seen a slight drop in 2020 due to the emergence of the pandemic situation, cancelled surgeries or leading to delayed. With the emergence of COVID-19, the United States faced extreme shortages of vital anesthesia drugs, mainly canceled surgeries, dexmedetomidine, midazolam, Propofol, and neuromuscular blocking agents. Most of the surgeries were delayed, and only acute surgical emergencies were managed. Thus, the COVID-19 has an unfavorable impact on the United States anesthesia drugs industry. As a result, numerous players are ramping up their production of anesthesia drugs. For instance, in 2020, Hikma Pharmaceutical introduced a new product, "Propofol Injectable Emulsion," in the United States.

 

General Inhalation Anesthesia is the Leading Segments in the United States Anesthesia Market

Based on type, the United States anesthesia drugs market includes the General Inhalation Anesthesia Drugs market, General Intravenous Anesthesia Drugs Market, and Local Anesthesia Drugs Market. General Inhalation Anesthesia Drugs Market holds a considerable market share; the inhaled anesthetics include desflurane, isoflurane, sevoflurane, and others that enhance inhibit excitatory synaptic activity and inhibitory postsynaptic channel activity. General intravenous anesthesia drugs are less costly and do not need expensive machines for administration. Moreover, intravenous anesthesia drugs result in undersized cardiovascular depression and better postoperative analgesia.

 

Besides, general intravenous anesthesia is the leading segment in the United States Anesthesia Market. Fospropofol Disodium, Propofol, Benzodiazepines Class, Ketamine, Methohexital Sodium, Pentobarbital, Etomidate, and Fentanyl are generally utilized general intravenous anesthesia in the United States. Propofol drug is one of the most frequently used general anesthetics in surgeries among these anesthesia drugs. It is utilized as a sedative for critical care (including COVID-19) in the ICU. It is used to maintain procedural sedation, initiate general anesthesia, etc. In  2020, the United States (FDA) Food & Drug Administration approved the usage of Fresenius Propoven 2% emulsion to maintain sedation in COVID-19 patients (16 years and above) requiring mechanical ventilation.

 

Competitive Landascape

The United States anesthesia drugs market is highly competitive and consists of several major players. Most of the anesthesia drugs trade is generic and are available at a low cost. The key players include Draegerwerk AG, Abbvie, Baxter International Inc., Endo International plc, and Koninklijke Philips NV.

 

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/united-states-anesthesia-drugs-market-and-forecast-31-p.php

 

Market Summary:

• Types – Renub Research Report covers United States Anesthesia Drugs Market by type in the 3 viewpoints (General Inhalation Anesthesia Drugs market, General Intravenous Anesthesia Drugs Market and Local Anesthesia Drugs Market)
• United States Anesthesia Drugs Market – This has been further break-up in 8 segments: Propofol, Benzodiazepines Class (Diazepam and Midazolam), Fospropofol Disodium, Ketamine, Methohexital Sodium, Pentobarbital, Etomidate, Fentanyl
• United States General Inhalation Anesthesia Drugs Market – This has been further break-up in 4 segments: Sevoflurane, Desflurane,   Isoflurane, Others
• United States Local Anesthesia Drugs Market – This has been further break-up in 7 segments: Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine, Other Local Anesthetics
• All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Draegerwerk AG, Abbvie, Baxter International Inc., Endo International plc, and Koninklijke Philips NV.

 

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

 

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

As per the latest report by Renub Research titled "Online Travel Market, Size, Global Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis" the Global Online Travel Market Size to Reach US$ 1,463.98 Billion by 2027. The internet revolution has transformed the scenario of the travel industry. Online travel providers aim to bookings for travelers and ease travel planning. Fast hotel bookings are driving the online travel industry and easy flights, increased consumer trust in online payment, and the option to compare viable available travel options. MakeMyTrip Limited, Trivago N.V, Trip.com Group Ltd., Trip Advisor Inc. extensively offers travel services through mobile websites and apps.

 

Worldwide Travel Market to Reach US$ 800.72 Billion by 2021

On the other hand, an increase in mobile, tablet, and desktop usage, a rise in internet penetration, and innovative mobile apps are the pivotal factors expected to stimulate the growth of the online travel industry. The change in disposable income of people in emerging markets and the ease of comparing various online travel options like direct and package are further anticipated to foster market growth. However, the COVID-19 pandemic had a significant impact on the online travel industry due to the travel restriction across the globe to prevent the pandemic from spreading. Moreover, due to interstate and local travel restrictions, trade fairs, hotel visits, and cultural events, online travel has been negatively affected in 2020.

 

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=online-travel-market-p.php

 

Online Travel Agencies are the Most Preferred Medium for Bookings Globally

By Booking Type, the market is categorized into Online Travel Agencies and Direct Travel Suppliers. In recent times, the online travel agency has become more and more common for customers to book trips themselves. As a result, many visitors have turned away from traditional brick-and-mortar travel agencies in favor of online alternatives to book their trips. Online travel agencies are those individuals or companies that have websites that allow consumers to book various travel-related services through the internet. Travel agents are employed in the sales of travel usefulness such as hotels, flights, buses, vacation packages, and rental cars via online networks.

 

Plenty of Payment Options

In terms of payment mode, UPI, E-Wallets, Debit/Credit Card, and Other has traditionally been the primary mode of paying for travel bookings online. Nowadays, using credit cards and debit cards to make payments is the norm even when not traveling. And when traveling, it is the most preferred method of payment. The ease and convenience of making a payment by swiping the card on a card machine or completing an online payment by typing the card details make this mode of payment safe. Mobile payment is another avenue which is also emerging in a big way for contact less and easy payment.

 

Travel accommodation service is projected to lead the online travel services market

On the basis of service types, the online travel market includes Transportation, Vacation Packages, and Travel Accommodation. Travel accommodation has become the most consequential contributor to the Online Travel Market. Travelers can choose online from various travel accommodations, including hotels, resorts, vacation rentals, and others. Travelers are increasingly being proposed a diverse range of hotel choices at affordable costs by Trip Advisor Inc., Booking Holding, Trip.com Group Ltd. Customers compare accommodation options at several websites to get the best reasonable deal. Travelers choose specialized online accommodation providers like OYO Rooms and Airbnb, Inc. because they provide many housing options.

 

Age groups of 32–43 years have more Desire to Travel

In terms of age group, the online travel market includes Millennial, Generation X, Baby Boomers, and Silver Hair. The travelers, primarily male and female in the age group of 32–43 years, occupy a considerable portion of the market. These age groups have more time, money, and the desire to travel. During their travels, they seek new adventures; participate in active vacations, including sightseeing and discovering new cultures.

 

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/online-travel-market-p.php

 

Asia Pacific (APAC) has the Highest Growth Potential in the Online Travel Industry

Region-wise, Asia-pacific gained an effective online travel market share. China and India are the most lucrative online travel markets. With rapid infrastructure development across seaports, railroads, hotels, airports, highways, and disposable incomes on the rise, travel opportunity continues to develop region wide. Further, the growth is attributed to greater penetration of internet facilities, increased disposable income, anda rise in the middle-class segment. Ctrip is the leading company in China's online travel market, whereas Yatra and MakeMyTrip are the significant online travel agencies (OTA) in India. The main companies operating in the global online travel industry include Airbnb, Expedia, Booking Holding, Trip Advisor Inc., Trip.com Group Ltd.

 

Market Summary:

• Type - The report covers by type in the 2 viewpoints into Package, Direct.
• Booking Type – Renub Research Report covers by Booking Type in the 2 viewpoints include Online Travel Agencies, Direct Travel Suppliers.
• Service Type – Our Report have covered by Service Type in the 3 viewpoints into Transportation, Vacation Packages, Travel Accommodation.
• Payment Mode- The report covers by Payment Mode in the 4 viewpoints include UPI,  E-Wallets, Debit/Credit Card, Other.
• Age Group - Our Report has covered online travel market breakup by 4 Age Group include Millennial, Generation X, Baby Boomers, and Silver Hair.
• Gender – This report covers by gender in the 2 viewpoints into Male, Female.
• Devices Type - Renub Research Report covers by Devices Type in the 2 viewpoints include Mobile/Tablet, Desktop.
• Region – We have covered region like North America, Western Europe, Asia Pacific, Latin America, Middle East and Africa, Central and Eastern Europe.
• All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Airbnb, Expedia, Booking Holding, Trip Advisor Inc., Trip.com Group Ltd. 

 

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

 

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

As per the latest report by Renub Research titled "Online Education Market, Size, Global Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis" the Global Online Education Market Size was USD 585.48 Billion in 2027. Recently, online education has become an essential part of the modern education system. Online education is an electronically supported learning framework, which depends on the internet for cooperation and appropriation of study material among understudies and instructors. Many drivers drive the Online Education Market. It offers both the students and teachers an efficient way to transfer knowledge by the mode of videos, PDFs, podcasts, etc., which are beyond the scope of paper and pen. It also offers accessibility of time and place, which helps the schools and other educational universities access, many other students.

 

Online education platforms are more affordable than general pen and paper models and are easy on the environment. Nonetheless, developing interest to decrease the expense of instruction, expanding government drives supporting online schooling, and growing infiltration of cell phones and the internet are the variables adding to the growth of the online education market. Similarly, the market growth is anticipated to be facilitated, attributing to the expanding interest for versatile and adaptive learning and the emergence of an AI-enabled e-learning solution.

 

COVID-19 Impact on Online Education Market

With the rise of the COVID-19 cases, all colleges, schools, and other learning institutes were closed due to the lockdown implemented to avoid the spread of the coronavirus. This fuled the growth of online education platforms as academic institutes embraced e-learning mediums to provide training and education for individuals during the COVID-19 executed lockdowns. In 2020, according to UNESCO (United Nations Educational, Scientific and Cultural Organization), over 1.2 billion students in 186 countries were impacted by school closures due to the COVID-19 pandemic. Countries that are worst smacked by the coronavirus have seen unprecedented growth in distance education enrollments.

 

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=online-education-market-p.php

 

Academic Institutions hold a Significant Market Share

On the basis of user's type, the online education market is segmented into government, academic and corporate. With the rising number of students in academic organizations and the regular need to upskill and provide industry-relevant training to the staff, academic institutions and corporations need to develop options that allow individuals to learn anytime from anywhere. Increased effectiveness of animated learning and flexibility in learning are other factors contributing to academic institutions' growth of online education. Lack of competent staff in various colleges and schools across the developing nations also results in the adoption of online schooling by the students. Support and government funds are other primary drivers for academic institutions' growth of online education.

 

Online Mobile e-learning is the Fastest-Growing Technology Segment

By technology, online e-learning delivers knowledge to students through electronic modes such as audio, e-books, videos, AR/VR, or any other electronic method. Online e-learning technology provides various benefits to the students, including low cost of education and specialized course learning. Additionally, online e-learning has become an integral part of the majority of institutions as it enhances the performance of employees. For instance, according to IBM statistics, e-learning can increase productivity by 50% by using online e-learning software to provide employees with an amazing opportunity to engage in their training courses at any suitable time. Apart from this, mobile e-learning is the fastest-growing technology segment due to increasing income levels, and then those dollars flowing into mobile sales in the developing countries have propelled the growth rate and growth prospects for mobile e-learning.

 

North America & Asia Pacific Online Education Market would Witness Market Growth

Online education in Asia Pacific has glimpsed an enhanced acceptance over a few years. It is an integral part of the colleges, schools, and even offices across Asia. One of the advantages of online education is that this kind of education model is efficiently scalable. The government is also allowing the universities to deliver fully online degrees, a change that could reshape the education industry in the country like India and China. Besides, the availability of high-speed internet and the advent of the 5G network in Asia-Pacific are delivering lucrative opportunities for market players to adopt innovative technologies.

 

Over the years, the increased penetration of the internet and the availability of low-cost smartphones has raised the number of online users in India. This has created a surge in demand for online education like K-12 education, vocational training, higher education in rural and urban areas. Similarly, the government in India is undertaking various digital initiatives such as ePathshala, which provides educational web resources for students, parents, teachers, researchers, and educators. Key players operating in the market include Coursera, Instructure Inc., Byju's, Adobe Inc., and Alphabet Inc.

 

Follow the link for the full report with detailed TOC and list of figures and tables:  https://www.renub.com/online-education-market-p.php

 

Market Summary:

User Type - We have covered Global Online Education Market breakup by 3 viewpoints by- User Type (Academic (Higher Education, Vocational Training, K-12 Education and Others), Corporate (Large Enterprise and SMBs and Government)

Provider - Renub Research Report covers by provider in the 2 viewpoints (Services and Content)

Technology - Our Report has covered Global Online Education Market breakup by 6 Technology (Online e-learning, Learning Management System (LMS), Mobile e-learning, Rapid e-learning, Virtual classroom and Others)

Region - This Report covers by Region in the 5 viewpoints (North America (United States and Canada), Europe (United Kingdom, Germany, France, Italy, Spain and Russia), Asia-Pacific (China, India, Japan, South Korea, Singapore and Australia), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), Middle East & Africa)

All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Coursera, Instructure Inc., Byju's, Adobe Inc. and Alphabet Inc.

 

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

 

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

As per the latest report by Renub Research titled “Pediatric Vaccines Market, Size, Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis" Pediatric Vaccines Market Size was US$ 47.8 Billion by 2021. The vaccines administered to stop children from contracting several infectious diseases and non-infectious are pediatric vaccines. These vaccines are heat-killed or inactivated viruses that lose their pathogenicity, i.e., the ability to cause disease. Additionally, these inactivated antigens can stimulate the immune system to produce antibodies against the infected virus.

 

Besides, pediatric vaccines are distributed to a child in its pediatric age, from 0 –18 years. Vaccines are commonly given to prevent children from diseases transferred through seasonal variations, infections, and even though unhygienic areas. Depending upon the disorder, the vaccines are administered at regular intervals. World Health Organization (WHO) has designed a standard immunization program to have desired time interval between vaccines doses.

 

Pediatric Vaccine Growth Factors

Globally, the growing prevalence of chronic disorders such as diphtheria, tuberculosis, and pneumonia in the age of 15 years and downward will contribute to the development of the pediatric vaccines industry. According to WHO, globally around 5 billion severe illnesses and 0.5 billion deaths yearly. As immunization plays a vital role in modern medicine, several international programs for children may vary based on the disease. Nevertheless, these programs are primarily driving the demand in the pediatric vaccines market. Further, the global pediatric vaccines market is driven by factors such as the global initiative undertaken by key players to develop innovative vaccines and increase government support.

 

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=pediatric-vaccines-market-p.php

 

The Combos Vaccine Segment is to Grow at a Significant Rate:

Based on Vaccine Types, the Pediatric Vaccine industry includes Influenza, MMR (Measles, Mumps, and Rubella Vaccine), Pneumococcal, Meningococcal, Hepatitis, DTaP, mophilus Influenzae Type B (HIB), Combos (Combination), Polio, Rotavirus, Varicella and Coronavirus (COVID-19). Infections are always a leading cause of mortality and morbidity in children under 5 years of age, most of which can be stopped by vaccination. However, too many vaccines are to be administered, increasing the cost of immunization and visits to the pediatrician. Combination vaccines can answer these problems until developing a single vaccine containing all the possible antigens.

 

Additionally, combination vaccines such as the 5-in-1 and the MMR have been developed to help reduce the number of injections needed. Even so, children and babies often receive several vaccines at once. For example, a 2-month-old baby will simultaneously obtain the 5-in-1, PCV, Rotavirus, and MenB vaccines. Moreover, as per our Report statistics, the number of infants vaccinated from Combination Vaccines across the world was 163.52 Million in 2021, and it increased appreciably to 339.04 Million by 2027.

 

COVID-19 Impact on Global Pediatric Vaccines Market:

The COVID-19 has upended the lives of children and their families. Therefore, amidst the pandemic, the global market for Pediatric vaccines dropped in 2020 as most healthcare personnel were busy in COVID-19 management. The pandemic naturally affected the routine immunization programs and campaigns conducted globally in developing and developed countries. The UNICEF and World Health Organization (WHO) warned of an alarming drop in the number of children receiving life-saving vaccines worldwide. This is due to troubles in the delivery and uptake of immunization services caused by the COVID-19 pandemic.

 

Regardless, Influenza vaccination rates have gone up considerably during the pandemic due to push from health experts/health departments and the extension of different government programs that provide free vaccination against the flu. Also, growing awareness among the public about the higher risk of getting infected with COVID-19 if the flu weakens the immune system is another factor contributing to the uptake of flu vaccines.

 

Key Players:

The pediatric vaccines industry consists of several major players, including GlaxoSmithKline, Plc, Merck & Co., Sanofi Pasteur’s, Pfizer, Inc.’s, CSL Limited. The companies enforce specific strategic initiatives like new product launches, mergers, acquisitions, and partnerships, which help them strengthen their market position.

 

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/pediatric-vaccines-market-p.php

 

Market Summary:

• Vaccine Types - We have covered Global Pediatric Vaccines Market & Numbers of Population breakup by 2 viewpoints by Vaccine Type (Influenza, MMR (Measles, Mumps, and Rubella Vaccine), Pneumococcal, Meningococcal, Hepatitis, DTaP, mophilus Influenzae Type B (HIB), Combos (Combination), Polio, Rotavirus, Varicella and Coronavirus (COVID-19))
• Regions - We have covered all the 5 Regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa in this report
• All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) GlaxoSmithKline, Plc, Merck & Co., Sanofi Pasteur’s, Pfizer, Inc.’s, CSL Limited.

 

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

 

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

As per the latest report by Renub Research titled "Oncology Precision Medicine Market, Size, Global Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis" the Global Oncology Precision Market Size will reach USD 64.66 Billion by 2027. Oncology precision medicine is an emerging trend in the healthcare industry that has been growing quickly in recent years. It makes the diagnosis of cancer and other diseases more accurate and evaluates the specific genetic makeup of their tumors to select the safest and most effective treatments for them. In cancer, precision medicine involves sampling DNA from patients' tumors to determine the mutations or other genetic changes that drive their cancer. Physicians then may select a treatment for a particular patient's cancer that best matches, or targets, the culprit mutations in the tumor DNA.

 

Likewise, some of the more common cancers where precision medicine is being used to help with treatment decisions include Lung Cancer, Stomach Cancer, Prostate Cancer, Liver Cancer, Oesophagus Cancer, Colorectal Cancer, Breast Cancer, r, cervical cancer, Kidney Cancer, and Bladder Cancer. Notwithstanding, the existing oncology precision medicine market is preferred by multiple factors, including several government initiatives, rising cancer incidences, and death rates, coupled with the general population's growing awareness about molecular-level diagnosis and treatment. Besides, the increasing number of advancements in molecular diagnostics, increasing FDA approvals for such precision medicine-based oncology drugs, enhancing focus on research and development activities by crucial healthcare companies also led to market expansion. Furthermore, the development of newer therapeutic approaches, including gene therapy for cancer treatment and a rising number of patients undergoing predictive diagnosis, will propel the market growth.

 

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=oncology-precision-medicine-market-p.php

 

COVID-19 Impact on Oncology Precision Market

COVID-19 has impacted the oncology precision medicine market. This impact was mainly due to disturbance of the supply chain and lockdowns imposed in many countries. Nevertheless, as the lockdowns were raised and supply was restored, the market has recovered quickly. As precision medicine deals majorly with fatal disorders like cancer involving life-saving drugs, the COVID-19 pandemic is poised to impact the market during the assessment period. Majorly for individuals living with cancer, the pandemic posed a unique set of challenges. The pandemic has certainly hindered surgeries and testing on biopsy tissue and has also impacted cancer patients' ability to receive provider-administered drugs. Thus, the volume of oncology precision drugs and services declined notably in 2020.

 

Hospital end-users accounted for the largest share of the global oncology precision medicine market

On the basis of end-user, the global oncology precision medicine market is categorized into Hospitals, Diagnostic Centers, Research & Academic Institutes, and Others. The hospital's segment accounted for the most significant market. The large share of this segment is primarily attributed to the rising number of tertiary/specialty care hospitals, rising incidence of cancer diseases, growing healthcare infrastructure, increasing demand for quality healthcare, and shift towards personalized/precision medicine. As per our research findings, Worldwide oncology precision medicine market was USD 33.40 Billion in 2021

 

North Americans raise oncology precision medicine production:

Geographically, North America is leading the oncology precision medicine market. The number of cancer patients in North America is growing notably. According to the (ACS) American Cancer Society, cancer is the leading reason of death in Canada and the second leading cause of death in the U.S. In U.S, about 1.8 million new cancer cases were diagnosed in 2020. High awareness in the region regarding precision medicine and increasing demand for personalized cancer treatment will drive the industry revenue in the region. The level of medical procedures, such as radiation, chemotherapy, and immunotherapy required, will depend upon the stage and type of cancer. Precision medicines play an essential role in helping physicians determine a suitable treatment plan based on the current genetic mutations of the patient.

 

Similarly, oncology precision medicine treatments have gained momentum among clients in the Asia-Pacific region in the past few years. They utilize advanced technologies and innovative methods to create personalized medicines that cater to patients' medical needs. The global precision medicine market players are Eli Lily and Co., F. Hoffmann – La Roche Ltd, Novartis AG, Bristol–Myers Squibb and AstraZeneca.

 

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/oncology-precision-medicine-market-p.php

 

Market Summary:

• Product Type – We have covered Global Oncology Precision Medicine Market breakup by 2 viewpoints by- product type (Diagnostics and Therapeutics)
• Indication – Renub Research Report covers by Indication in the 11 viewpoints (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Oesophagus Cancer, Cervical Cancer, Kidney Cancer and Bladder Cancer)
• End Users – Our Report has covered Global Oncology Precision Medicine Market breakup by 4 End Users (Hospitals, Diagnostic Centers, Research & Academic Institutes and Others)
• Region - This Report covers by Region in the 5 viewpoints (North America, Europe, Asia Pacific, Latin America and the Middle East & Africa)
• All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Eli Lily and Co., F. Hoffmann – La Roche Ltd, Novartis AG, Bristol–Myers Squibb and AstraZeneca.

 

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

 

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

As per the latest report by Renub Research titled "Oncology Precision Medicine Market, Size, Global Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis" the Global Oncology Precision Market Size will reach USD 64.66 Billion by 2027. Oncology precision medicine is an emerging trend in the healthcare industry that has been growing quickly in recent years. It makes the diagnosis of cancer and other diseases more accurate and evaluates the specific genetic makeup of their tumors to select the safest and most effective treatments for them. In cancer, precision medicine involves sampling DNA from patients' tumors to determine the mutations or other genetic changes that drive their cancer. Physicians then may select a treatment for a particular patient's cancer that best matches, or targets, the culprit mutations in the tumor DNA.

 

Likewise, some of the more common cancers where precision medicine is being used to help with treatment decisions include Lung Cancer, Stomach Cancer, Prostate Cancer, Liver Cancer, Oesophagus Cancer, Colorectal Cancer, Breast Cancer, r, cervical cancer, Kidney Cancer, and Bladder Cancer. Notwithstanding, the existing oncology precision medicine market is preferred by multiple factors, including several government initiatives, rising cancer incidences, and death rates, coupled with the general population's growing awareness about molecular-level diagnosis and treatment. Besides, the increasing number of advancements in molecular diagnostics, increasing FDA approvals for such precision medicine-based oncology drugs, enhancing focus on research and development activities by crucial healthcare companies also led to market expansion. Furthermore, the development of newer therapeutic approaches, including gene therapy for cancer treatment and a rising number of patients undergoing predictive diagnosis, will propel the market growth.

 

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=oncology-precision-medicine-market-p.php

 

COVID-19 Impact on Oncology Precision Market

COVID-19 has impacted the oncology precision medicine market. This impact was mainly due to disturbance of the supply chain and lockdowns imposed in many countries. Nevertheless, as the lockdowns were raised and supply was restored, the market has recovered quickly. As precision medicine deals majorly with fatal disorders like cancer involving life-saving drugs, the COVID-19 pandemic is poised to impact the market during the assessment period. Majorly for individuals living with cancer, the pandemic posed a unique set of challenges. The pandemic has certainly hindered surgeries and testing on biopsy tissue and has also impacted cancer patients' ability to receive provider-administered drugs. Thus, the volume of oncology precision drugs and services declined notably in 2020.

 

Hospital end-users accounted for the largest share of the global oncology precision medicine market

On the basis of end-user, the global oncology precision medicine market is categorized into Hospitals, Diagnostic Centers, Research & Academic Institutes, and Others. The hospital's segment accounted for the most significant market. The large share of this segment is primarily attributed to the rising number of tertiary/specialty care hospitals, rising incidence of cancer diseases, growing healthcare infrastructure, increasing demand for quality healthcare, and shift towards personalized/precision medicine. As per our research findings, Worldwide oncology precision medicine market was USD 33.40 Billion in 2021

 

North Americans raise oncology precision medicine production:

Geographically, North America is leading the oncology precision medicine market. The number of cancer patients in North America is growing notably. According to the (ACS) American Cancer Society, cancer is the leading reason of death in Canada and the second leading cause of death in the U.S. In U.S, about 1.8 million new cancer cases were diagnosed in 2020. High awareness in the region regarding precision medicine and increasing demand for personalized cancer treatment will drive the industry revenue in the region. The level of medical procedures, such as radiation, chemotherapy, and immunotherapy required, will depend upon the stage and type of cancer. Precision medicines play an essential role in helping physicians determine a suitable treatment plan based on the current genetic mutations of the patient.

 

Similarly, oncology precision medicine treatments have gained momentum among clients in the Asia-Pacific region in the past few years. They utilize advanced technologies and innovative methods to create personalized medicines that cater to patients' medical needs. The global precision medicine market players are Eli Lily and Co., F. Hoffmann – La Roche Ltd, Novartis AG, Bristol–Myers Squibb and AstraZeneca.

 

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/oncology-precision-medicine-market-p.php

 

Market Summary:

• Product Type – We have covered Global Oncology Precision Medicine Market breakup by 2 viewpoints by- product type (Diagnostics and Therapeutics)
• Indication – Renub Research Report covers by Indication in the 11 viewpoints (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Oesophagus Cancer, Cervical Cancer, Kidney Cancer and Bladder Cancer)
• End Users – Our Report has covered Global Oncology Precision Medicine Market breakup by 4 End Users (Hospitals, Diagnostic Centers, Research & Academic Institutes and Others)
• Region - This Report covers by Region in the 5 viewpoints (North America, Europe, Asia Pacific, Latin America and the Middle East & Africa)
• All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Eli Lily and Co., F. Hoffmann – La Roche Ltd, Novartis AG, Bristol–Myers Squibb and AstraZeneca.

 

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

 

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

As per the latest report by Renub Research titled “Global Dialysis Market, Size, Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis" Global Dialysis Market Size was USD 92.5 Billion in 2021. Worldwide, dialysis is an essential and life-saving treatment for chronic renal failure (CRF), kidney diseases, end-stage renal disease (ESRD). Dialysis is a treatment that purifies blood using a machine. It utilizes special equipment to remove excess water and waste products from the blood. In this procedure, the blood is filtered, excess toxins and fluid are removed, and electrolyte balance is restored. Dialysis is carried out in two ways: peritoneal and hemodialysis dialysis. Both perform the usual filtering of waste kidney functions and excess fluid from the blood.

 

Key Factors Driving the Growth of the Dialysis Industry:

Dialysis market growth is driven by the increasing diabetic population, higher prevalence among ageing population, and rising cases of ESRD are anticipated to drive the market. Further, an increase in the advancement of home-based services and the number of treatment centers are the aspects attributing toward the dominance of the services segment. Moreover, improved reimbursement policies for renal treatment by private and public institutions are encouraging the expansion of the market at a remarkable rate. For instance, in 2020, according to the End-Stage Renal Disease (ESRD) PPS final rule, the Centers for Medicare & Medicaid Services (CMS) to pay around US$ 10.3 billion in Medicare reimbursements to about 7,000 ESRD providers for the costs of delivering renal hemodialysis services.

 

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=global-dialysis-market-p.php

 

How Coronavirus Affected the Dialysis Industry

Besides, the COVID-19 pandemic had a moderate impact on the market. COVID-19 is majorly a respiratory disease, but it has also been shown to impact kidneys, damaging the organ to cause acute renal infection (AKI). The pandemic also disrupted the supply chain operations and affected the availability of hemodialysis, consumables for peritoneal dialysis, and essential medicines, leading to a drop in dialysis procedures performed in several dialysis centers. Due to such adverse scenarios, the overall impact of the COVID-19 pandemic on the market is to be substantial.

 

Hemodialysis to Account for Maximum Share

Based on type, the dialysis market is bifurcated into hemodialysis and peritoneal dialysis. The hemodialysis segment is a significant contributor to the dialysis market growth. Hemodialysis helps balance minerals such as sodium, calcium, and potassium that aids in decreasing blood pressure. Routine hemodialysis is conducted in a hospital, dialysis outpatient facility, or a dedicated stand-alone clinic that surges the market demand. Also, the growing prevalence of chronic kidney diseases across the globe will boost the acceptance rate of hemodialysis among the patient population base. Hemodialysis is classified into short daily, conventional hemodialysis, hemodialysis, and nocturnal hemodialysis.

 

In terms of end-users, the dialysis market is segmented into in-center and home dialysis. Dialysis treatments centers accounted for the significant market, attributable to the favorable reimbursement provided by renal facilities. Most patients prefer to obtain dialysis treatments through services delivered by dialysis centers making them the most significant contributor to the global dialysis market. Regardless, a rise in awareness and surge in demand for home healthcare among dialysis patients is predicted to make home dialysis the fastest-growing segment during the forecast period. Home dialysis offers several benefits, including reducing travel expenses, improved quality of life, flexibility, and accessible patient mobility.

 

Rising Dialysis Cases in the North American Region will Fuel the Industry's Progression:

Amongst regions worldwide, North America is projected to lead the dialysis market owing to the higher usage of dialysis therapy to treat several end-stage renal diseases and chronic kidney diseases. The high prevalence of CKD and ESRD in the U.S. and Canada, coupled with higher treatment rates in these countries, are the pivotal factors estimated to boost the expansion of the market during the forecast period. Further, the North American region is projected to see growth attributable to the growing incidence of coronavirus infections and succeeding renal failures. Likewise, the Asia-Pacific region is anticipated to witness the growth in dialysis market during the coming year, which is attributed to a low rate of organ transplantation, surge in the incidence rate of kidney failure, and advancement in healthcare expenditure.

 

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/global-dialysis-market-p.php

 

Competitive Landscape

The prominent players operating in the dialysis market include Baxter International Inc, Fresenius Medical Care, DaVita Inc, Asahi Kasei Corporation, and Medtronic Plc. These variant market participants are undertaking various progressive strategies to capture a higher revenue share in this dialysis market. Several development strategies enforced by foremost market players have helped them maintain a strong position in the industry.

 

Market Summary:

• Type - We have covered Global Dialysis Market breakup by 2 viewpoints by Type (Hemodialysis, Peritoneal dialysis)
• Product & Services - Renub Research Report covers by Product & Services in the 4 viewpoints (Services, Equipment, Consumables, and Drugs)
• End-Users - Our Report has covered Global Dialysis Market breakup by end-users 2 viewpoints (In-center dialysis, Home dialysis)
• Regions - Global Dialysis Market has covered by Region 5 viewpoints (North America, Europe, Asia Pacific, South America, Middle East and Africa)
• All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Baxter International Inc, Fresenius Medical Care, DaVita Inc, Asahi Kasei Corporation, and Medtronic Plc.

 

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

 

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

As per the latest report by Renub Research titled “Global Dialysis Market, Size, Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis" Global Dialysis Market Size was USD 92.5 Billion in 2021. Worldwide, dialysis is an essential and life-saving treatment for chronic renal failure (CRF), kidney diseases, end-stage renal disease (ESRD). Dialysis is a treatment that purifies blood using a machine. It utilizes special equipment to remove excess water and waste products from the blood. In this procedure, the blood is filtered, excess toxins and fluid are removed, and electrolyte balance is restored. Dialysis is carried out in two ways: peritoneal and hemodialysis dialysis. Both perform the usual filtering of waste kidney functions and excess fluid from the blood.

 

Key Factors Driving the Growth of the Dialysis Industry:

Dialysis market growth is driven by the increasing diabetic population, higher prevalence among ageing population, and rising cases of ESRD are anticipated to drive the market. Further, an increase in the advancement of home-based services and the number of treatment centers are the aspects attributing toward the dominance of the services segment. Moreover, improved reimbursement policies for renal treatment by private and public institutions are encouraging the expansion of the market at a remarkable rate. For instance, in 2020, according to the End-Stage Renal Disease (ESRD) PPS final rule, the Centers for Medicare & Medicaid Services (CMS) to pay around US$ 10.3 billion in Medicare reimbursements to about 7,000 ESRD providers for the costs of delivering renal hemodialysis services.

 

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=global-dialysis-market-p.php

 

How Coronavirus Affected the Dialysis Industry

Besides, the COVID-19 pandemic had a moderate impact on the market. COVID-19 is majorly a respiratory disease, but it has also been shown to impact kidneys, damaging the organ to cause acute renal infection (AKI). The pandemic also disrupted the supply chain operations and affected the availability of hemodialysis, consumables for peritoneal dialysis, and essential medicines, leading to a drop in dialysis procedures performed in several dialysis centers. Due to such adverse scenarios, the overall impact of the COVID-19 pandemic on the market is to be substantial.

 

Hemodialysis to Account for Maximum Share

Based on type, the dialysis market is bifurcated into hemodialysis and peritoneal dialysis. The hemodialysis segment is a significant contributor to the dialysis market growth. Hemodialysis helps balance minerals such as sodium, calcium, and potassium that aids in decreasing blood pressure. Routine hemodialysis is conducted in a hospital, dialysis outpatient facility, or a dedicated stand-alone clinic that surges the market demand. Also, the growing prevalence of chronic kidney diseases across the globe will boost the acceptance rate of hemodialysis among the patient population base. Hemodialysis is classified into short daily, conventional hemodialysis, hemodialysis, and nocturnal hemodialysis.

 

In terms of end-users, the dialysis market is segmented into in-center and home dialysis. Dialysis treatments centers accounted for the significant market, attributable to the favorable reimbursement provided by renal facilities. Most patients prefer to obtain dialysis treatments through services delivered by dialysis centers making them the most significant contributor to the global dialysis market. Regardless, a rise in awareness and surge in demand for home healthcare among dialysis patients is predicted to make home dialysis the fastest-growing segment during the forecast period. Home dialysis offers several benefits, including reducing travel expenses, improved quality of life, flexibility, and accessible patient mobility.

 

Rising Dialysis Cases in the North American Region will Fuel the Industry's Progression:

Amongst regions worldwide, North America is projected to lead the dialysis market owing to the higher usage of dialysis therapy to treat several end-stage renal diseases and chronic kidney diseases. The high prevalence of CKD and ESRD in the U.S. and Canada, coupled with higher treatment rates in these countries, are the pivotal factors estimated to boost the expansion of the market during the forecast period. Further, the North American region is projected to see growth attributable to the growing incidence of coronavirus infections and succeeding renal failures. Likewise, the Asia-Pacific region is anticipated to witness the growth in dialysis market during the coming year, which is attributed to a low rate of organ transplantation, surge in the incidence rate of kidney failure, and advancement in healthcare expenditure.

 

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/global-dialysis-market-p.php

 

Competitive Landscape

The prominent players operating in the dialysis market include Baxter International Inc, Fresenius Medical Care, DaVita Inc, Asahi Kasei Corporation, and Medtronic Plc. These variant market participants are undertaking various progressive strategies to capture a higher revenue share in this dialysis market. Several development strategies enforced by foremost market players have helped them maintain a strong position in the industry.

 

Market Summary:

• Type - We have covered Global Dialysis Market breakup by 2 viewpoints by Type (Hemodialysis, Peritoneal dialysis)
• Product & Services - Renub Research Report covers by Product & Services in the 4 viewpoints (Services, Equipment, Consumables, and Drugs)
• End-Users - Our Report has covered Global Dialysis Market breakup by end-users 2 viewpoints (In-center dialysis, Home dialysis)
• Regions - Global Dialysis Market has covered by Region 5 viewpoints (North America, Europe, Asia Pacific, South America, Middle East and Africa)
• All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Baxter International Inc, Fresenius Medical Care, DaVita Inc, Asahi Kasei Corporation, and Medtronic Plc.

 

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

 

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

As per the latest report by Renub Research titled "Bioplastic Market, Size, Global Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis" the Global Bioplastic Market Size was USD 6.7 Billion in 2021. Bioplastic is recognized as a very positive and essential innovation in the plastics and chemicals industry. Bioplastic is materials emanated from renewable sources that can reduce plastic waste generation on the planet. It can reduce 30-70% of carbon dioxide emissions. It represents an approximately 42% reduction of carbon footprints. The production of bioplastic requires 65% less energy than conventional petroleum plastic. These bio-based plastics are generally sourced from renewable biomass sources, including vegetable fats, natural sugars, cellulose, plant starch, and waste oils.

 

Over the short term, significant factors driving the market studied are environmental factors promoting a paradigm shift and increasing demand for bioplastics in flexible packaging. The ecological dilemma caused by reaching high levels of greenhouse gas emissions in the atmosphere is one of the main drivers for the bioplastic industry, as bioplastic help to reduce the dependency on fossil resources, reduce greenhouse gas (GHG) emissions, and increase resource efficiency.

 

COVID-19 Impact on Bioplastics Growth Trends

The bioplastic market was positively impacted by COVID-19. Amid the lockdown situation, the demand for flexible packaging has increased, owing to the rise in demand for food, pharma, and PPE packaging personal and healthcare products. However, sustainable plastics can be an excellent alternative to conventional plastics, thus delivering an alternative growth pathway to the bioplastic industry in the wake of the COVID -19 pandemic.

 

Request a Free Sample Copy of the Report:  https://www.renub.com/request-sample-page.php?gturl=bioplastics-market-p.php

 

Non-biodegradable Plastics Polyethylene Terephthalate (PET) Segment led the Market

Non-biodegradable bioplastic are further categorized into Polyethylene (P.E.), Polyethylene terephthalate (PET), Polyamide (P.A.), Polypropylene (P.P.), Poly(trimethylene terephthalate) (PTT) and Others. Polyethylene terephthalate is an ideal choice for use in various industries such as automotive, electronics, and textiles due to its features. Polyethylene terephthalate, commonly known as PET, is a lightweight, non-toxic, safe, and flexible material that can be reused and recycled efficiently. It can also be processed 3 to 4 times without impacting its chemical properties. Meanwhile, polyethylene terephthalate offers unique physical properties, such as it is shatterproof and non-reactive to food and water, so it is widely utilized in flexible packaging applications. The growing technological advances and innovations in packaging applications, mainly through weight reduction, will positively influence market growth.

 

Packaging Application is anticipated to Exhibit Rapid Growth

The adoption of bioplastic has increased tremendously across various applications like packaging, agriculture, consumer goods, textile, automotive and transportation, and building and construction, owing to the advanced technical properties and functionalities. Bio-based plastics have found traction in packaging applications due to shipping companies seeking sustainable sturdy packaging products. The packaging segment is further divided into jars, trays, bottles & and others, while flexible packaging is further categorized into shopping/waste, pouches, bags, etc. Moreover, most packaging products are nowadays produced from traditional plastics and end up in landfills, which is a situation that various governments intend to address.

 

Regionally, North America accounted for the Largest Bioplastics Market

North America's bioplastics market is majorly caused by the growing demand from the packaging industry in countries like Canada, U.S., and Mexico. Rising environmental concerns and a global attempt to decrease pollution are propelling the demand for biodegradable plastics in the packaging sector across the region. In addition, increasing COVID-19 cases in the U.S. results in a raised demand for generic drugs and medical devices, this boosts the demand for bioplastics in the medical packaging sector, positively impacting the market growth.

 

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/bioplastics-market-p.php

 

Similarly, Asia Pacific is likely to have a considerable market due to the availability of skilled labor at a low cost. Further, easy land availability for manufacturing industries drives the regional market. The transformation in the production landscape of biodegradable plastics toward emerging economies, particularly China and India, is to influence bioplastics market growth positively. The bioplastics market is fragmented into key players like Total Corbion (Netherlands), Mitsubishi Chemical Holding Corporation (Japan), Toray Industries (Japan), Biome Bioplastics (U.K.), Green Dot Bioplastics.

 

Market Summary:

Material Type - We have covered Bioplastics Market breakup by 2 viewpoints by- Material Type (Biodegradable (Polybutylene adipate Terephthalate (PBAT),Polybutylene Succinate (PBS),Polylactic Acid (PLA),Polyhydroxyalkanoate (PHA),Starch Blends and Others), Non Biodegradable (Polyethylene (PE),Polyethylene terephthalate (PET),Polyamide (PA), Polypropylene (PP,Polytrimethylene terephthalate) ( PTT) and Others))

Application - Renub Research Report covers by application in the 6 viewpoints (Packaging, Agriculture, Consumer Goods, Textile, Automotive and Transportation, And Building and Construction)

Region – Our Report has covered Bioplastics Market breakup by 4 Region (North America, Europe, Asia Pacific and Rest of the Word)

All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Total Corbion (Netherlands), Mitsubishi Chemical Holding Corporation (Japan), Toray Industries (Japan), Biome Bioplastics (U.K.), Green Dot Bioplastics.

 

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

 

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

According to Renub Research, report titled “Spinal Fusion Market, Size, Share, Global Forecast 2022-2027, Industry Trends, Growth, Outlook, Impact of COVID-19, Company Analysis” the Global Spinal Fusion Device Market was USD 7.48 Billion in 2021. Surgical procedures and implant-device (cage) technologies for spinal fusion have evolved dramatically over 40 years. Furthermore, design and materials have developed with a single purpose in mind: to create implants that satisfy all three critical concerns of the procedure: stability, lordosis restoration, and osteointegration. As a result, spinal fusion remains the gold standard for treating spinal instability, deformity, and degenerative illness. Spinal fusion, also known as spinal arthrodesis, is a surgical operation that involves joining two or more vertebral bodies in the spine.

 

Worldwide Spinal Fusion Device Market is anticipated to grow at a CAGR of 4.8% from 2021-2027

The global spinal fusion devices market is predicted to increase moderately, opening up a slew of new prospects. The increase in the elderly population and the rise in the frequency of spinal illnesses are driving the market's expansion. In addition, the market is expected to rise as the number of indications for spinal fusion surgery grows. For example, spinal fusion was once reserved for scoliosis and spinal tuberculosis, but it is now used to treat 14 other disorders. It's also worth noting that technological advancements are helping to drive the business forward.

 

Request a Free Sample Copy of the Report:  https://www.renub.com/request-sample-page.php?gturl=global-spinal-fusion-market-procedure-volume-and-forecast-495-p.php

 

The Thoracolumbar Devices Segment Is the Market Leader:

By product type, Cervical Device, Thoracolumbar Device, Interbody Device, and Biologics are covered in our report. According to our research, the thoracolumbar devices category dominates the spinal fusion device market. The segment is being driven even further by the rising incidence of spinal problems such as spinal stenosis, severe kyphosis, and vertebral fracture. In most of these cases, surgery is the only choice for treatment. Furthermore, thoracolumbar fractures can be the most common reason for surgical intervention. Road accidents or bone insufficiency are the two most common causes of fractures. Bone insufficiency is caused by underlying conditions such as osteoporosis and tumors, weakening the bone and leading to fractures.

 

The Degenerative Disc Segment Is Rapidly Growing:

In our report, we have studied Degenerative Disc Disease, Complex Deformity, and Traumas & Fractures as disease indicator types. Over the projection period, the complex deformity segment would dominate the market for spinal fusion devices. On the other hand, expanding reasons for lower back and neck discomfort in adults and an increase in the older population are the main factors driving the degenerative disc segment. In addition, the evolution of sports and daily activities is predicted to contribute to category expansion. As a result, according to our analysis, the degenerative disc section of the spinal fusion market is expected to multiply.

 

End-user Perspectives on the Spinal Fusion Device Industry:

Our report covers Ambulatory Surgical, Specialty Clinics, and Hospitals. For decades, one of the elements propelling the hospital segment has been the increasing number of spine procedures conducted in hospitals. Furthermore, in developing countries such as India, significant government measures to enhance healthcare infrastructure and develop the middle-class population result in augmented demand for excellent healthcare services offered by hospitals, assisting segment expansion. As a result, according to our analysis, hospitals are expected to dominate the market for spinal fusion devices by the end-user.

 

The Market for Spinal Fusion Devices in Different Regions:

Our analysis divides the world into five regions: North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. The growing geriatric population in North America and the increased incidence of sports injuries and fatal accidents are among the primary drivers driving demand for spinal fusion devices in the North American region. Furthermore, the region's well-developed healthcare infrastructure will likely drive market expansion for spinal fusion devices. Furthermore, essential player advancements are projected to enhance market growth by creating substantial untapped opportunities.

 

Insights for Key Players:

Alphatec Holdings, Inc., B. Braun Group, Johnson & Johnson, Globus Medical, Medtronic, NuVasive, ORTHOFIX MEDICAL INC, Stryker, and Zimmer Biomet Holdings are some of the leading companies in the spinal fusion device market. With numerous large and small industry participants, the market for spinal fusion devices is very competitive. To get a more extensive market share, these companies pursue strategies such as geographical expansion, new product releases, partnerships, and collaborations.

 

Follow the link for the full report with detailed TOC and list of figures and tables:  https://www.renub.com/global-spinal-fusion-market-procedure-volume-and-forecast-495-p.php

 

COVID-19's Impact on the Global Spinal Fusion Device Market:

The COVID-19 epidemic has had an impact on just about every business. The market for spinal fusion devices, like other healthcare industries, has been completely impacted. The COVID-19 epidemic situation in several nations has created obstacles for spinal fusion devices used in hospitals and clinics to provide orthopedic services. One of the problems preventing clinics and hospitals from providing spine fusion services is the enormous strain on hospitals to offer COVID-19 patients.

 

Market Summary:

• Product Type: We have covered Cervical Device, Thoracolumbar Device, Interbody Device an Biologics as product type.
• Surgery Type: In our report we have studied, Open Surgery, Minimally Invasive
• Disease Indicator Type: We have studied, Degenerative Disc Disease, Complex Deformity, Traumas & Fractures and Other
• End-Users: Hospitals, Specialty Clinics and Ambulatory Surgical are the end-users covered in our report
• Regions: In our report we have covered, North America, Europe, Asia-Pacific, Latin America and Middle East & Africa
• Company Analysis: The key players covered are Alphatec Holdings, Inc., B. Braun Group, Johnson & Johnson, Globus Medical, Medtronic, NuVasive, Orthofix Medical Inc, Stryker, Zimmer Biomet Holdings)

 

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

 

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

According to Renub Research, report titled “Ready to Drink Tea and Coffee Market, Size, Global Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Company Analysis” the Ready to Drink Tea and Coffee Market is expected to reach US$ 153.19 Billion by 2027. Globally, tea and coffee that are ready to drink are packaged beverages sold in a ready-to-drink state. To replace nutritional shortages, RTD tea and coffee can also be modified to deliver personalized health benefits to consumers, especially for children and women. As a result, young people in both developed and developing countries are switching to RTD beverages for a quick boost of energy instead of synthetic sports drinks. Furthermore, ready-to-drink tea and coffee can be used as a substitute for carbonated drinks. Remarkably, Ready to Drink Tea is regarded as a healthy beverage. At the same time, Ready to Drink Coffee is considered a reliable source of immediate energy.

 

Worldwide Ready-to-Drink Tea and Coffee Market was valued at US$ 100.10 Billion

In recent years, due to customers' busy and fast-paced lifestyles, ready-to-drink tea and coffee has seen increased demand as an alternative to carbonated drinks. In addition, changing lifestyles that encourage on-the-go eating and a growing tendency of substituting less nutritious snacks for meals has increased by global Ready to Drink Tea and Coffee acceptance. As a result, the market has been developing moderately with considerable growth rates over the last few years. It is anticipated to increase significantly in the anticipated period, i.e., 2021-2027.

 

Request a Free Sample Copy of the Report:  https://www.renub.com/request-sample-page.php?gturl=ready-to-drink-tea-and-coffee-market-p.php

 

How COVID-19 Benefited the Ready-to-Drink tea and Coffee Industry

The global ready-to-drink tea and coffee market rose due to the COVID-19. Restaurants, cafés, tea micro-roasters, and other out-of-home outlets have all been harmed by measures such as social separation and lockdowns. Nonetheless, the present trend toward online purchase for consumption at home is forcing retailers, roasters, and consumers to adjust to this new reality. As a result, this factor boosts the global consumption of RTD coffee and tea. As a result, demand for RTD tea and coffee increased in 2020, resulting in increased RTD tea and coffee retail sales.

 

Ready To Drink Tea Segment Holds a Significant Share of The Global Tea And Coffee Market:

Our report divides the market into two product categories: ready-to-drink tea and ready-to-drink coffee. The fastest-growing segment was Ready to Drink tea owing to the availability of the most appropriate tea tastes, such as fruit, black, green, herbal, matcha, oolong, and iced, as well as additional nutritional benefits such as necessary vitamins and minerals and a high supply of antioxidants. For example, catechin is present in RTD green tea. On the other hand, RTD coffee comes in a variety of flavors, including yerba mate, guarana, acai berry, ginseng, taurine, and iced varieties. In contrast, black coffee is high in vitamin B, potassium, magnesium, polyphenols, and caffeine.

 

The PET Bottle Segment is expected to have the largest market share:

The RTD tea and coffee industry is divided into four categories based on packaging: glass bottle, PET bottle, canned, and others. The PET bottle category is expected to have the most significant share in the worldwide RTD tea and coffee market. Notwithstanding, PET receptacles are in high demand among liquid manufacturers in the beverage packaging business because they are recyclable.

 

Distribution Channels in Ready-To-Drink Coffee and Tea Industry:

As per our analysis, ready-to-drink coffee and tea distribution are controlled by distribution channels such as supermarkets/hypermarkets, specialty stores, online stores, and others. Due to the significant increase in demand, Supermarkets/Hypermarkets and Specialty Stores are increasingly selling high-quality coffee and tea at cheap costs, appealing to busy consumers and effectively reacting to their lifestyles.

 

North America Has the Fastest-Growing Market for Ready-To-Drink Tea and Coffee:

As per our report estimates, due to increased consumer knowledge about the negative consequences of carbonated beverages, North America is the fastest-growing ready-to-drink tea coffee industry. Furthermore, due to increased demand for these products, Canada and the United States are driving the RTD tea and coffee business expansion in North American region. Moreover, the entire sector in the United States is expanding as the country's health awareness grows.

 

Follow the link for the full report with detailed TOC and list of figures and tables:  https://www.renub.com/ready-to-drink-tea-and-coffee-market-p.php

 

Key Market Players:

According to our report, Suntory Holdings Ltd, Nestle SA, Asahi Group Holdings Ltd, Uni-President Enterprises, PepsiCo Inc, The Coca-Cola Company, Starbucks Corporation, Monster Beverage Company, Danone, and Unilever are among the market's key players. Furthermore, the analysis includes a global overview, recent developments/initiatives, and the revenue of the players mentioned above.

 

Market Summary:

• Product Category: We have studied the market for RTD Tea, RTD Coffee as product categories in Ready to Drink Tea and Coffee Industry.
• Packaging: Our report covers PET Bottle, Glass Bottle, Canned, Others as packaging used in Ready to Drink Tea and Coffee Market.
• Distribution Channels: In our report we have studied Supermarket/Hypermarket, Specialty Stores, Online Store and Others as distribution channels of Ready to Drink Tea and Coffee Industry.
• Region: We have studied the regional market of North America, Europe, Asia Pacific, Middle East & Africa, South America in Ready to Drink Tea and Coffee Market.
• Company Analysis: Our report studies key players like Suntory Holdings Ltd, Nestle SA, Asahi Group Holdings Ltd, Uni-President Enterprises, PepsiCo Inc, The Coca-Cola Company, Starbucks Corporation, Monster Beverage Company, Danone, and Unilever.

 

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

 

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

According to latest report by Renub Research, titled “Radiofrequency Based Devices Market, Global Forecast 2022-2027, Industry Trends, Growth, Size, Impact of COVID-19, Company Analysis” the Radiofrequency Based Devices Market is expected to reach US$ 6.6 Billion by 2027. Healthcare experts have discovered radiofrequency is one of the most rapidly evolving technologies. In the last few decades, reducing the impact of surgical interventions on patients has been the direction of evolution for surgery. Recognizing the benefits, such as low post-operative recovery time, low blood loss, complications, the lower possibility for post-operative infections, and above all, the lower chance of requirement of a revision procedure, minimally invasive surgical technologies have been witnessing remarkable growth in demand for Radio frequency-based devices across the globe.

 

Radiofrequency Based Devices Market

Furthermore, the growing demand for MIS procedures has resulted in massive demand for image-guided ablation treatments. One of the predominant image-guided treatments is radiofrequency ablation (RFA) in minimally invasive surgical techniques. RFA has appeared as the most commonly used technology for thermal ablation in the kidney, liver, lung, bone, heart, breast, lymph nodes, nerves, and soft tissues. Radio frequency-based devices are also utilized in aesthetic treatments, such as skin tightening, body contouring, wrinkle reduction, skin and neck laxity, and others in a non-invasive manner.

 

Moreover, the market is driven by certain factors, including advancing the geriatric population, rising incidence of chronic disorders, increasing demand for minimally invasive surgical procedures, growing healthcare spending in developing economies, and technological advancements in ablation and aesthetic treatments.

 

Request a Free Sample Copy of the Report:  https://www.renub.com/request-sample-page.php?gturl=radiofrequency-based-devices-market-p.php

 

Worldwide Radiofrequency Based Devices Market Size was US$ 3.4 Billon in 2021

On the basis of product type, the radio frequency-based devices industry has been segmented into radiofrequency generators, applicators, needles, electrodes, cannulas, probes, and others. The radiofrequency generators have a significant market. In pain management, a radiofrequency generator sends small magnitude radiofrequency current using insulated needle electrodes to deaden nerves transmitting pain signals to the brain. Further, RF micro-needling is a minimally invasive procedure using a conventional micro-needling technique with radiofrequency energy for skin rejuvenation.

 

Pain Management Segment have Significant Market Share

Among the application, the radio frequency-based devices market includes aesthetics devices, pain management devices, gynaecology devices, cardiology devices, oncology devices, and others. The pain management segment accounted for a considerable market. Radiofrequency treatment is considered to be very useful in long-term chronic pain management. Radiofrequency ablation produces the benefits of being accurate, effective, and reproducible to a great extent.

 

In addition, radiofrequency-based aesthetic devices are used for minimally invasive treatments such as RF micro-needling, which is used to rejuvenate the formation of skin. Additionally, advancements in radiofrequency-based aesthetic devices feature mixtures of multiple technologies. These technological advancements make significant market players develop products to serve radiofrequency ablation and aesthetic procedures.

 

North America Radiofrequency Based Devices Market to be one of the Largest Market Globally

Geographically, North America is the most substantial market for RF devices, attributed to the growing investment in research and development of advanced radiofrequency appliances, rising plurality of chronic diseases, and increased healthcare expenditure. In addition, the RF ablation devices industry in this region is overpowered by the U.S. due to a wide installation base for such devices in the country.

 

The Asia Pacific radiofrequency-based devices market has significant growth due to the large patient pool suffering from chronic pain, increasing demand for cosmetic skincare and growing geriatric population. For instance, the World Population Ageing report states that there were 395.3 million ageing people aged 65 years or overhead, and the number will reach 954.7 million by 2050.

 

COVID-19 Impact on Radiofrequency Based Devices Market Growth Trends

The COVID-19 outbreak has disturbed various trades and businesses across the world. Due to coronavirus spreading, many cities are shutting down, causing treatments and doctor’s appointment cancellations. Nevertheless, the coronavirus pandemic has harmed the RF devices market due to the sudden shift in the focus toward COVID-19 treatment. In addition, the concerned activities on radiofrequency-based surgeries stopped and were postponed; the market encountered a fall.

 

Follow the link for the full report with detailed TOC and list of figures and tables:  https://www.renub.com/radiofrequency-based-devices-market-p.php

 

Competitive Landscape

The key players such as Abbott Laboratories, ALMA Lasers (Sisram Medical Ltd), AtriCure, Inc., Medtronic plc, Stryker, Conmed Corporation, Smith & Nephew plc, Boston Scientific Corporation, Inc have launched new products, predominantly involved in M&A activities, and ventured into synergistic collaborations aimed at either co-developing new technologies or supporting consumer reach by integrating marketing efforts of both the companies.

 

Market Summary:

Product - We have covered Market breakup by 4 viewpoints by- product (Generators, Radiofrequency Probes, Electrodes and Cannulas)

Application – Our report have covered Market breakup by 6 viewpoints by application (Aesthetics Devices, Pain Management Devices, Oncology Devices, Gynecology Devices, Cardiology Devices, and Others)

End User - Our Report covers by End Users in the 3 viewpoints (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics)

Region - This Report covers Global Radiofrequency Based Devices Market breakup by 5 Region (North America, Europe, Asia Pacific, Latin America and Middle East Africa)

All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Abbott Laboratories, ALMA Lasers (Sisram Medical Ltd), AtriCure, Inc., Medtronic plc, Stryker, Conmed Corporation, Smith & Nephew plc, Boston Scientific Corporation, Inc

 

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

 

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

According to Renub Research report titled “Medical Adhesives Market, Share, Global Forecast 2022-2027, Industry Trends, Growth, Size, Impact of COVID-19, Company Analysis” the Medical Adhesives Market to reach USD 15.30 Billion by 2027. In the assembly of medical devices, medical adhesives comprise an integral part of healthcare delivery and are used by almost every medical specialty in all care settings. Medical adhesives are biocompatible, and their features of not irritating, sensitizing, or cytotoxic have expanded their use in medical equipment. Medical adhesives are majorly utilized in the medical industry to close up a patch or dress the skin wounds, fix medical devices such as tape, etc. It is utilized for bone and enamel reconstruction during surgeries. Various products are involved in medical adhesives, such as dressing, electrodes, patches tapes, and ostomy supplies.

 

Worldwide Medical Adhesives Market Size was US$ 9.70 Billion in 2021

Nonetheless, the population in developed countries such as the U.S., Germany, and Japan is aging rapidly. As per the United States Census Board, people above 65 years would account for 20% of the total population by 2030. According to the (UNU) United Nations University, one million people reach 60 years of age every month globally. The increasing geriatric population is the factor that increases medical adhesives demand, which in turn anticipated driving the development of the global market in the next few years. Further, the demand for silicone-based medical adhesives is caused by their ability to adhesion silicon and other difficult-to adhere substrates. In addition, silicone is characterized by extreme weather resistance and has more extended durability than acrylics.

 

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=medical-adhesives-market-p.php

 

Dental application is the Fastest-growing Segment of Medical Adhesives Industry

In terms of application, the global medical adhesives market is categorized into medical device & equipment, internal, external, dental, and others. Dental adhesives deliver retention to composite fillings or composite cement. These adhesives find use in pit & fissure sealants and dental repair applications. Products in dental applications include Pit and Fissure Sealants, Restorative Adhesives, Denture Bonding, Orthodontic Bonding, Luting Cements, Dental Surgical Tissue Bonding, and Tray Adhesives.

 

Apart from this, medical devices & equipment are utilized for hearing-aid molding, polycarbonate component assembly (e.g., heat exchangers, blood oxygenators, and surgical pumps) anesthesia-mask bonding, needle assembly, bonding of other medical devices. The product's substrate versatility, thermal solid & chemical resistance, low shrinkage, high gap filling, high peel, and rapid cure are the significant factors driving their growth in medical devices & equipment.

 

North America to Lead Global Medical Adhesives Industry

In North America, increased patient awareness levels regarding wound infections and diseases and the rapidly growing senior population in this region, especially in the U.S, are the significant factors contributing to market growth. The evolution of the market player’s focus towards developed wound dressings analogized to the traditional staple and suture methods is the major trend witnessed in this region.

 

Notwithstanding, the Asia Pacific is the fastest-growing medical adhesive market. The Asia-Pacific medical adhesive market is predicted to expand due to the growing population, driving up the need for better medical facilities and preferring adhesive medical demand. The consistent increase in government spending on the healthcare sector and the updating of healthcare infrastructure are market expansions in this area.

 

COVID-19 Impact on Medical Adhesive

The pandemic had ramifications for ways of working of various surgical procedures. There are stringent guidelines specific to each specialty that must be implemented and followed for surgeons to continue providing adequate care and safety to their patients during the COVID-19 pandemic. The volume of surgeries has significantly declined during the pandemic, owing to the stringent guidelines by the regulatory authorities to avoid all non-emergent surgeries, impacting the procurement of the medical adhesives market.

 

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/medical-adhesives-market-p.php

 

Key Market Players

Numerous big and small players characterize the global medical adhesives market. The major market players include Avery Dennison Corporation, Ashland Global Holdings Inc., H.B. Fuller Company, Henkel AG & Co. KGaA, The Dow Chemical Company, 3M Co, PPG Industries, RPM International Inc., Dupoint De Nemours, Inc and Wacker Chemie AG.

 

Market Summary:

Product - We have covered Market breakup by 2 viewpoints by product (Synthetic & Semi-Synthetic Adhesives (Acrylic, Polyurethane, Epoxy, Silicone, and Others) and Natural or Biological Adhesive (Fibrin, Collagen, Albumin, and Others)

Application - Our Report covers by Application in the 5 viewpoints (Dental (Pit and Fissure Sealants, Restorative Adhesives, Denture Bonding, Orthodontic Bonding, Luting Cements, Dental Surgical Tissue Bonding, and Tray Adhesives), Internal (Bone, Cranial, Pulmonary and Abdominal), External (Tissue Bonding Agents and Prosthesis Bonding Agents), Medical Device & Equipment and Others)

Technology – Global Medical Adhesives Market have been covered by technology from 5 viewpoints (Water based, Solvent based, Hot melt, Reactive & Others)

Region - This Report covers Global Medical Adhesives Market breakup by 4 Region (North America, Europe, Asia - Pacific, Central & South America, and Middle East)

All the key players have been covered from 3 Viewpoints (Recent Development, Overview, and Revenue Analysis) H.B. Fuller Company, Henkel AG & Co. KGaA, Avery Dennison Corporation, Ashland Global Holdings Inc., The Dow Chemical Company, 3M Co, PPG Industries, RPM International Inc., Wacker Chemie AG, and Dupoint De Nemours, Inc.

 

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

 

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

According to the latest report by Renub Research, “United States Cardiovascular Devices Market Forecast 2021-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis” United States Cardiovascular Devices Market Size was US$ 25.34 Billion in 2020. Cardiovascular diseases, or CVDs in the United States, have continued to be considered among the top pain counts of the medical application. Additionally, with conditions like stroke or IHD (ischemic heart disease) adding heavily to death and disability, cardiovascular devices and their consequence in heart-related therapies are quickly being brought into the spotlight in the country. Further, fatalities caused due to CVDs have been rising steadily over the years.

 

According to a study by Communicable Disease Center (CDC), one of the major operating components of the Department of Health and Human Services and recognized as the nation's premier health promotion, prevention, and preparedness agency, claims heart attack to be the principal cause of death for men, women, and people of most significant racial and ethnic groups in the United States. Consequently, these alarming situations are a testament that the U.S. need to implement cost-effective health devices and therapies designed to mitigate the risk of CVDs. Wherein development and deployment of effective and advanced medical devices is a crucial part of these efforts.

 

Move Towards Minimally Invasive Treatment Solutions:

In the United States, minimally invasive surgical procedures, especially in the cardiovascular discipline, have continued to gain favour over the years due to myriad benefits like minimal damage to the body, less pain, and lower risk of complications correlated to open operations. Drawn initially to match in the mid-90s, the MIS procedures accompanied the realization of the preeminent coronary artery and heart valve bypass employing the least access routes.

 

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=united-states-cardiovascular-devices-market-p.php

 

Further, the preference for minimally invasive procedures is driven by advancements in cardiovascular medical device technologies. These developments are instrumental in positioning minor invasive procedures as the operating method of choice. They rely heavily on catheters and other specialized medical equipment to be injected into the body through tiny cuts for therapeutic intrusions and demonstrative measures.

 

For instance, innovative discoveries like smart balloon catheter systems are decked with electronics, sensors and mechanisms. The intelligent technology is consistently redesigned to deliver ablation therapy, blood flow data, haematological data and electrical instigation through a single device. In September 2020, a unit of researchers led by technicians at Northwestern University and George Washington University outlined a balloon catheter system. It was implemented with flexible and stretchable patterns of electrode actuators and sensors and pressure and temperature sensors. These are frequently used in minimally invasive ablations or surgeries in operating conditions such as heart arrhythmias.

 

The Emergence of Sophisticated and Innovative Cardiac Ablation Devices:

As the burden of cardiovascular ailments in the United States medical realm remains to grow over the years, the adoption of superior treatment technologies will behold a significant upsurge, creating productive growth roads for the cardiovascular device industry in the years ahead. By Device Type, Renub Research holds meaningful existence of devices like Peripheral Vascular Device, Prosthetic Heart Valves, Cardiac Rhythm Management Device, Cardiac Assist Devices, Cardiovascular Surgery Devices, External Defibrillators, Clot Management Devices and Cardiovascular Prosthetic Devices in the United States Cardiovascular Devices Market. Wherein, the rising prevalence of atrial fibrillation is an essential contributor to the popularity of these devices. Remarkably, in cardiac ablation device technologies, the products are inscribing an ever-increasing demand for minimally invasive ablation procedures and discovery.

 

For example, in June 2020, Boston Scientific launched the DIRECTSENSE technology in the United States as a tool intended to monitor the impact of radiofrequency energy delivery through cardiac ablation processes. Similarly, in 2020, Abbott restarted its LIFE-BTK clinical trial to assess the safety and effectiveness of its new Esprit BTK Everolimus-Eluting Resorbable Scaffold System. This is the advancing investigational device exemption (IDE) trial in the United States to assess an utterly bio-resorbable stent to heal blocked arteries underneath the knees, or critical limb ischemia (CLI), in people undergoing the first stages of peripheral artery disease (PAD).United States Cardiovascular Devices Market will grow with a CAGR of 6.7% during 2021-2027.

 

The evident reinforcement of the cardiovascular devices market is hinged through key end-users like Hospitals, Cardiac Diagnostic Centres and Ambulatory Surgical centres factoring the risk of CVDs and related health problems are recognized today on a grander scale the region. Further, the market growth can be attributed to a thriving healthcare recognition through visibility on the internet, private hospital heart plans and public outreach plans from government bureaus like the CDC. In addition, consumers are alert to the symptoms of developing a heart disorder, the need for early diagnosis and available treatment options. The fast-expanding geriatric population base will only fuel the potential of the medical devices sector.

 

Consequently, heart disease is the preeminent instigator of death in the United States, affecting a large population in the United States each year. Precisely, more than millions of Americans are living with some form of cardiovascular disease or stroke. In addition to the rising pervasiveness of CVD, there is a surge in comorbidities, which involves chronic pain, arrhythmias, diabetes and depression, and are more widespread in the elderly medicare groups. Given the expected uptick in CVD, comorbidities, and blended analysis and medication, the financial strain of CVD also is expected to expand, with the determined direct cost of CVD in the US.

 

The consequence of COVID-19 Pandemic against Cardiovascular Device Industry:

Amidst the first half of 2020, the COVID-19 pandemic has negatively impacted the cardiovascular devices industry. The Coronavirus has modified the production of cardiovascular devices businesses as there was a postponement of elective procedures. Only those cardiovascular projects were analyzed, which were critical; others have been suspended and limited since the commencement of the global pandemic.

 

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/united-states-cardiovascular-devices-market-p.php

 

Another factor negatively influencing the industry was the deterioration in the analysis of cardiovascular diseases as the healthcare devices were being redirected to Coronavirus patients. However, the monthly revenues of cardiovascular devices companies rebounded in H2 2020 and are back on track.

 

Market Summary:

Device Type - We have covered the market comprising of Cardiac Rhythm Management Device, Peripheral Vascular Device, Prosthetic Heart Valves, Cardiac Assist Devices, Cardiovascular Surgery Devices, External Defibrillators, Clot Management Devices, Cardiovascular Prosthetic Device, Others.

End–Users - We have studied the market Hospitals, Cardiac Diagnostic Centres, and Ambulatory Surgical Centre existing as end users in the United States Cardiovascular Devices

Company - We have studied the company by Company Overview, Recent Development and Financial Insights of following companies Abbott Laboratories, Boston Scientific Corporation, Edwards Life sciences, Cardinal Health Inc., Medtronic PLC, and GE Healthcare.

 

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

 

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

According to the latest report by Renub Research, “Point of Care Diagnostic Market Size, Global Forecast 2021-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” the Point of Care Diagnostics Market is expected to be USD 44 Billion by 2027. Point-of-care testing is essential for rapidly detecting analyses near the patient, facilitating better monitoring, disease diagnosis, and management. POC tests are executed outside central laboratories and produce quick results. POC has been a vital goal in vitro diagnostics, and new consequences have made achieving it possible. Point of care diagnostics will be part of a paradigm shift from corrective medicine to predictive, personalized, and preemptive treatment.

 

Around the world, the demand for POC diagnostics is rapidly growing because of the prevalence of acute and chronic diseases. As per World Health Organization (WHO), in 2019, about 10 million people were impacted by tuberculosis globally, and 1.4 million people died from tuberculosis. Moreover, according to the United Nations Program on HIV/AIDS (UNAIDS), worldwide; around 37.7 million people were living with HIV in 2020. The demand for diagnosis products among patients is probable to boost the POC diagnostics market growth.

 

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=point-of-care-diagnostic-market-p.php

 

Factors Driving Point of Care Testing Market

Furthermore, Point-of-care is gaining wide acceptance by different patients worldwide, as samples are collected from the patient’s location for tests. The results can be achieved significantly less due to micro fluids, nano diagnostics, and chips. Factors such as the increasing regulatory support for novel immunoassay techniques, technological advancements, and the rising usage of home-based POC devices drive market growth. Point-of-care testing diagnostics have numerous advantages, which allow patient diagnoses at many places, such as in the ambulance, physician’s office, home, field, or hospital. The upshots of care are timely and quickly remedy the patient.

 

How COVID-19 Benefited the Global Point Of Care Diagnostics Industry:

The COVID-19 pandemic has dramatically affected the point of care diagnostics market. The outbreak of COVID-19 has expedited the global demand for diagnostic kits to detect the disease rapidly. Regardless, owing to the increasing usage of POC tests that can rapidly diagnose COVID-19. With the enlargement in demand for speedy diagnostic results, the adoption of point-of-care testing is booming. The rapidly extending number of COVID-19 cases and the growing pressure on governments to improve patient management have raised the demand for rapid antigen testing kits that can be virtually used in point-of-care settings.

 

Coagulation Monitoring Testing is the Major Revenue Share

Based on Diagnostics type, Point-of-care testing (POCT) diagnostics market segmented into Glucose Monitoring Infectious Disease, Pregnancy & Fertility Testing Market, Hematology Testing, Cardiometabolic Monitoring, Coagulation Monitoring, Urinalysis, and Tumor Markers. The rising number of patients suffering from bleeding disorders such as Von Willebrand, hemophilia, and venous thromboembolism generate considerable demand for Coagulation Monitoring testing.

 

Worldwide the rising prevalence of diabetes demands for Blood glucose testing point-of-care diagnostics due to the triumph of hand-held glucose meters, owing to their high adoption rate among the population across the world. Periodic monitoring of glucose levels is vital for diabetic patients, encouraging POC adoption among diabetic patients. Nevertheless, technology such as Lateral Flow technology uses across healthcare. There is an enormous demand for this segment owing to the advantage offered by lateral flow assay assays in POC testing by replacing lengthy, conventional laboratory procedures.

 

Regional Analysis: United States Controls the Point of Care Diagnostics Industry

Currently, the United States has highest market for point-of-care-diagnostics globally. This can be attributed to the country's growing geriatric population base and the aspects such as the increasing plurality of disorders and the flawless government regulations and initiatives undertaken for the evolution of healthcare infrastructure. Besides, the Asia-Pacific industry is to witness considerable enlargement due to the higher adoption of POC diagnostics kits in India. China is another significant factor supporting the growth in the Asia Pacific region.

 

Follow the link for the full report with detailed TOC and list of figures and tables:  https://www.renub.com/point-of-care-diagnostic-market-p.php

 

Competitive Landscape:

The point-of-care diagnostics market is relatively competitive and consists of several major players such as Sysmex, Abbott Laboratories (US, Becton Dickinson and Company (US), Danaher Corporation (US), Quidel Diagnostics (US)

 

Market Summary:

• Diagnostics Types – Renub Research Report covered by Diagnostics Types in the 8 viewpoints (Glucose Monitoring Infectious Disease, Pregnancy & Fertility Testing Market, Hermatology Testing, Cardio metabolic Monitoring, Coagulation Monitoring, Urinalysis, and Tumor Markers)
• Technology - Our Report covers by Technology in the 5 viewpoints (Biosensor, Lateral Flow, Agglutination, Flow Through, Solid phase)
• End User - We have covered Point of Care Diagnostics Market by  End User in the 4 viewpoints (Hospital, Clinics, Diagnostic centers, others)
• Country - This Report covers Point of Care Diagnostic Market breakup by 12 country (United States, China, Japan, United Kingdom, Germany, Spain, Italy, Argentina, India, Brazil, Canada, Mexico)
• All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Sysmex, Abbott Laboratories (US, Becton Dickinson and Company (US), Danaher Corporation (US),Quidel Diagnostics (US)

 

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

 

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

According to the latest report by Renub Research “Proton Therapy Market Size, Share, Global Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” the Global Proton Therapy Market Size was US$ 68.1 Billion in 2021. Proton therapy is an excellent treatment alternative for numerous patients, especially those with tumors close to vital organs. Besides, for children, those most vulnerable and susceptive to the damage of conventional radiation therapy, proton therapy offers less radiation exposure while demoting side effects. In addition, proton therapy is a high-tech option for X-ray radiation. With online image guidance, a scanning beam of proton radiation advises greater precision to destroy carcinogenic cells, sparing adjacent healthy tissue with more infrequent side effects.

 

Factors Fuelling the Growth of the Global Proton Therapy Market:

The growth of the proton therapy market across the world is mainly driven by rising healthcare expenditure, expanding preference for advanced therapies by healthcare practitioners, increasing confirmation, and increasing cancer pervasiveness. Another outstanding growth driver is the faster uptake and access and premium pricing. Further, the Worldwide Proton Therapy Market is growing at a CAGR of 2.07% during the period 2021-2027.

 

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=global-proton-therapy-market-and-forecast-12-countries-market-data-patients-treated-at-proton-therapy-centers-reimbursement-policies-1073-p.php

 

The United States has the Largest Number of Proton Therapy Centres Globally:

The United States is the proton therapy industry's hub, having the highest number of proton therapy hubs globally. The United Kingdom is anticipated to launch advanced multi-room proton therapy centers owned by the NHS and Private Players in the future. Besides, the emerging countries are also escalating their demand for proton therapy in their territories as some cancer and cancer-related cases have been surging and will undoubtedly boost the growth of this market during the forecast period.

 

Competitive Landscape:

Companies existing in the Global Proton Therapy Market are trying to create their mark by adopting new technologies at an accelerated rate. The company has also tried to enrich its product catalogs through product developments. Also, companies have acquired small companies to resolve the potential resource gap that prevailed in their technologies and products. The major players in the Global Proton Therapy Market studied in our report are IBA Proton Therapy, Varian Medical Systems, and Elekta.

 

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/global-proton-therapy-market-and-forecast-12-countries-market-data-patients-treated-at-proton-therapy-centers-reimbursement-policies-1073-p.php

 

COVID-19 Impact on Global Proton Therapy Industry:

Despite the outbreak of COVID-19 worldwide, the proton therapy market has expanded at a constant rate. Proton radiation therapy was discontinued for a brief round period, but it was renewed for patients. In addition, to take care of the regular patient and radiation therapies patients across the world, many processes have been finalized to help the patients with therapies; as such many implementations and algorithms have been carried out to safeguard the radiation patients from COVID-19.

 

Market Summary:

• Countries: In our report we have covered the proton therapy market of United States, United Kingdom, Switzerland, Russia, Germany, France, Italy, Sweden, Poland, Japan, Korea, China,
• Company: We have covered the key players including IBA Proton Therapy, Varian Medical Systems, Elekta

 

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

 

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

According to the latest report by Renub Research titled, “Lung Cancer Screening Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19, Opportunity Company Analysis” the Global Lung Cancer Screening Market Size was US$ 15.4 Billion in 2021. Lung cancer is the ultimate cause of cancer death among both women and men globally. Thus, lung cancer screening aims to detect lung cancer before it has spread; this can help find cancer early. However, the only recommended screening test for lung cancer is low-dose computed tomography (also called a low-dose C.T. scan, or LDCT), Chest x-ray, and Sputum cytology. Screening with LDCT scans has been conferred to decrease the risk of dying from lung cancer in heavy smokers. Screening by chest x-rays and sputum cytology does not reduce the risk of dying of lung cancer. Furthermore, lung cancer screening is a method used to detect lung cancer in otherwise healthy people with a high risk of lung cancer.

 

Worldwide Lung Cancer Screening Industry to Grow with a CAGR of 1.4% from 2021 to 2027

According to Statista the increasing incidence of lung cancer death is one of the significant factors driving the lung cancer screening industry. For instance, in 2020, around 1.79 Million cancer deaths, or 18% of all cancer deaths worldwide, were attributed to lung cancer. Further, the increasing number of screening test approvals from regulatory bodies is to drive the growth of the lung cancer screening market. For instance, in 2021, the U.S. Food and Drug Administration (FDA) announced approval for Amgen’s Sotorasib to treat patients with metastatic non-small cell lung cancer (NSCLC) or locally advanced with KRAS G12C mutation.

 

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=lung-cancer-screening-market-p.php

 

Non-small Cell Lung Cancer (NSCLC) Segment Holds the Lion’s Share

Based on cancer type, the global lung cancer screening market is segmented into non-small cell lung cancer (NSCLC) and small cell lung cancer. For instance, according to the (ACS) American Cancer Society, about 84% of all lung cancers are non-small cell, and 13% are SCLC. The growing awareness about screening in developed and developing countries combined with the ever-increasing cases of NSCLC across the globe demand for screening lung cancer type is done with a test called a spiral computed tomography or low-dose helical (C.T. or CAT) scan.

 

Healthcare like Hospitals & Clinics, Research institutes, and Diagnostic Centers play an active role in making people aware and educated about lung cancer screening. Doctors used conventional chest X-rays to check for signs of lung cancer, such as a suspicious spot. While traditional X-rays help detect lung cancer, they offer less detailed pictures from one angle than more advanced imaging technology, like C.T. scans, that use X-rays from multiple angles to make clear images of the lungs. Moreover, because of the National Lung Screening Trial and support from leaders in lung cancer treatment and prevention, low-dose C.T. scans of the chest are a standard of care in hospitals across the world.

 

Lung Cancer Incidence and Mortality in China have been Increasing Rapidly

Geographically, United States holds the most crucial requirement for lung cancer screening due to the rising lung cancer cases, progressing implementation of technologically advanced solutions and robust application of cancer screening courses, which are few of the aspects accountable for the domination of United States. For instance, as per the American Society of Clinical Oncology (2020), lung cancer is the second greatest basic cancer occurring in men and women and was assessed to affect more than 235,000 adults in the U.S.

 

In Germany, the lung cancer screening industry has grown due to increasing cancer awareness and introducing new medical diagnostic equipment and advanced therapies. The expanding elderly population, changing lifestyles, and rising tobacco smoking, including passive smoking, are likely drivers for the German lung cancer screening market. Likewise, as per the Global Cancer Observatory (Globocan), around 64,804 new cases of lungs cancer were identified in Germany in the year 2020.

 

COVID-19 Outbreak:

The outbreak of COVID-19 has hindered the lung cancer screening market since its arrival. This pandemic has created a commotion in the supply chain of clinical material. Consequently, there has been a rise in demand for global imaging solutions. Nevertheless, disruption in production and the industrial procedure has led to a disadvantageous impact on the market globally.

 

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/lung-cancer-screening-market-p.php

 

Robust Portfolio, Strong Distribution Network, and New Product Launch to help Key Players Lead

The global lung cancer screening market is consolidated with key players, including llumina, Inc, Abbott Laboratories, Thermo Fisher Scientific, Inc, QIAGEN N.V. and Roche Holding AG. The dominance of these major companies is attributed to the strong product portfolio of screening devices, robust distribution network, mergers and acquisitions, and introduction of new products in the market.

 

Market Summary:

• Cancer Type - We have covered Global Lung Cancer Screening Market breakup by 2 viewpoints by Cancer Type (Non-small cell lung cancer (NSCLC) and Small cell lung cancer)
• End User - Renub Research Report has covered by End User in the 4 viewpoints (Hospitals & Clinics, Research institutes and Diagnostic Centers and Others)
• Country – Our Report has covered Lung Cancer Screening Market breakup by 3 countries (United States, Canada, Norway, Italy, France, Germany, United Kingdom, Russia, Spain, China, India, Japan and South Korea)
• All the key players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) llumina Inc, Abbott Laboratories, Thermo Fisher Scientific Inc, QIAGEN N.V. and Roche Holding AG.

 

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

 

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

According to the latest report by Renub Research, “4K Medical Imaging Market, Share, Global Forecast 2022-2027, Industry Trends, Growth, Size, Impact of COVID-19, Company Analysis” the 4K Medical Imaging Market is expected to be USD 1.7 Billion by 2027. Digital medical imaging technology has grown rapidly in the last few decades and is widely used as a medical diagnostic tool. The medical enterprise is in the throes of entering a unique epoch in imaging technology. Healthcare specialists are upgrading to ultra-high-definition 4K resolution as innovative technology delivers four times more clarity than high definition. 4K imaging is a display panel that delivers high-definition video.The 4K technology has changed the perspective of the healthcare sector. The technology allows access of images that will ultimately help in providing efficient treatment.

 

Further, imagine seeing tissue, blood vessels, and organs in detail in richer detail than full HD. The sharper 4K picture provides a more real-to-life clarity of color and detail, making microsurgical crucial in minimally invasive and general surgery procedures. Now everyone in the OR (operating room) can have a better realistic view of the procedure. Video and still images caught and displayed in 4K give surgeons and clinical staff enhanced perception of fine details during complex procedures with virtually no pixilation.

 

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=4k-medical-imaging-market-p.php

 

Factors Influencing the 4K Medical Imaging Industries

• The increasing need for hybrid operational rooms is the primary factor that will benefit the global 4K medical imaging industry.
• Rising healthcare expenditure is forecast to offer ample opportunities for companies flourishing in the global .
• The 4K medical imaging market is witnessing increasing demand for visualization quality for medical imaging. Furthermore, growing cases of chronic diseases increase the demand for technologically advanced products.
• The rising demand for flexible designs of 4K medical imaging technology will propel the market growth during the forecast period.

 

COVID-19 Impact on 4K Medical Imaging Growth Rate

The COVID-19 pandemic has resulted in economic disruption for various countries. This worldwide pandemic has suddenly burdened the healthcare bodies and caused the governments to focus on the COVID-19 related healthcare infrastructure. Due to this the demand for 4K imaging technologies has decreased for a short period of time. Disruptions in the supply chain also reduced market development. Due to labor unavailability and raw materials, various manufacturing companies had to halt the activities. Therefore, it impacted the global 4K medical imaging industry.

 

Worldwide 4K Medical Imaging Market Size was USD 855.8 Million in 2021

Based on type, the 4K medical imaging market is segmented into 4K camera systems, 4K medical displays, and 4K Advanced Visualization Systems (Microscopic Systems). The 4K medical displays are growing immensely in the 4K medical imaging industry due to the fast adoption of hybrid operating rooms. It provides various advantages such as integrating different facilities, time, and cost-effectiveness. Similarly, the patients’ data of other devices are displayed on the desired display and offers better visualization quality, further propelling the blossoming of the 4K medical imaging market. Likewise, the 4K medical display market includes medical displays 4K UHD (3840*2160) and 4K DCI (4096*2160) medical displays.

 

North America 4K Medical Imaging Market is Driving the Growth Worldwide

Geographically, North America is the most considerable market for 4K medical imaging, owing to the growing demand for advanced technology in the region healthcare sector. In addition, favorable government initiatives increased healthcare expenditure, and prominent players like STERIS would contribute to the market development. The rising awareness about the benefits and high-resolution properties of 4K medical imaging technology further boosts the devices' demand. Moreover, the increasing geriatric population and the growing prevalence of chronic diseases will benefit the regional market.

 

Follow the link for the full report with detailed TOC and list of figures and tables:  https://www.renub.com/4k-medical-imaging-market-p.php

 

Competitive Landscape

The primary players covered in the 4K medical imaging industry are Sony Corporation, B. Braun Melsungen, Stryker Corporation, Smith & Nephew plc, Eizo Corporation, Stryker, Conmed Corporation, Medtronic plc, Siemens Healthineers, Zimmer Biomet Holdings, Inc.

 

Market Summary:

• Type - We have covered Market breakup by 4 viewpoints by type (4K Display, 4KIP Cameras, 4K Advanced Visualization Systems, and Others (4K Surgical Recorder, 4K Surgical Monitors)
• End User - Our Report covers by End Users in the 3 viewpoints (Hospitals, Diagnostic Centers and Others)
• Region - This Report covers Global 4K Medical Imaging Market breakup by 4 Region ( North America, Europe, Asia- Pacific and Rest of World)
• The key companies have been covered from 3 Viewpoints (Recent Development, Overview, and Revenue Analysis) Sony Corporation, B. Braun Melsungen, Stryker Corporation, Smith & Nephew plc, Eizo Corporation, Stryker, Conmed Corporation, Medtronic plc, Siemens Healthineers, Zimmer Biomet Holdings, Inc.

 

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

 

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch

According to Renub Research report, tittled “Cardiovascular Surgical Devices Market, Size, Global Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” finds the Cardiovascular Surgical Devices Market was USD 49.77 Billion in 2021. Globally, cardiovascular diseases are common life-threatening acute diseases. The rise in chronic cardiovascular diseases like heart failure and coronary artery disease (CAD), heart attack, atrial fibrillation, the opening of narrowed arteries, and coronary heart diseases repeatedly require technologically advanced cardiovascular surgical devices. Thus, cardiovascular surgical devices are increasingly important in cardiovascular disease to reduce mortality and medical disability and have made significant contributions to patient care.

 

Furthermore, perfusion disposables, cardiopulmonary bypass equipment, beating heart surgery treatment, and ventricular assist type devices help treat life-threatening cardiac diseases such as heart attack, atrial fibrillation, coronary heart diseases, and the opening of narrowed arteries. These surgical devices are utilized in cardiac surgery, one of their primary applications. These products also enable heart-lung machines employed during open-heart surgeries such as heart valve replacement, coronary artery bypass grafting, and other such procedures.

 

Market Drivers of the Cardiovascular Surgical Devices Industry

The majority of the deaths worldwide are due to cardiac diseases; according to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death globally, 17.9 million people died from CVDs in 2019, representing 32% of all global deaths due to stroke and heart attack. These factors majorly propel the growth of the cardiovascular surgical devices market.

 

Request a Free Sample Copy of the Report:  https://www.renub.com/request-sample-page.php?gturl=cardiovascular-surgical-device-market-p.php

 

In addition, a rise in incidences of atherosclerosis, diabetes, hypertension, strokes, and other chronic disorders that occur due to change in lifestyle habits (such as unhealthy dietary habits, smoking, and lack of physical activity) also boosts the growth of the cardiac surgical devices industry.

 

Worldwide Cardiovascular Surgical Device Market Size was US$ 49.77 Billion in 2021

Based on end-user, the cardiovascular surgical devices market is segregated into Hospitals, Cardiac Diagnostic Centers, and Ambulatory Surgical Centers. The high footfall, well-developed infrastructure, and increased healthcare expenditure have made the hospital the most preferred end-use extension. Further, a surge in the volume of surgeries due to the expanding prevalence of heart disorders and other diseases in hospitals is to boost the segment's development. Additionally, the increased demand for cardiac surgeries is expanding the number of operating rooms, aiding the part's development, correspondingly boosting the growth of the Global Cardiovascular Surgical Devices Industry.

 

Cardiac Rhythm Management Devices are to Witness Rapid Growth:

In terms of application, cardiac rhythm management (CRM) devices are extensively used to treat arrhythmia, tachycardia, bradycardia, and sudden cardiac arrests. Since the majority of cardiac rhythm conditions are growing, the adoption of cardiac management devices has improved significantly during the past decade. Besides, emerging nations are witnessing a huge demand for these devices due to a higher prevalence of cardiac conditions, raising awareness about products amongst the population. Besides, interventional cardiology surgery is the sub-specialty of cardiology that uses intravascular catheter-based techniques with fluoroscopy to treat coronary artery, valvular, and congenital cardiac diseases.

 

North America is the Biggest Cardiovascular Surgical Devices Market

Geographically, North America is an essential market for cardiovascular surgical devices due to the rising geriatric population and deaths related to cardiovascular disorders that demand cardiovascular surgical devices in the region. For instance, according to American Heart Association (AHA), 43.7 million aged above 60 suffer from cardiovascular disorders in the US. Due to these factors, many surgeries are being performed, thereby driving the market. Besides, countries like China, India, and Japan significantly demand cardiovascular surgical devices in Asia-Pacific due to the expanding prevalence of chronic cardiovascular diseases and the high adoption of advanced devices.

 

Impact of Covid-19 on Cardiovascular Surgical Devices Industry

The COVID-19 pandemic hit the production of cardiovascular surgical devices. The discontinuation of elective procedures due to COVID-19-related measures has negatively affected the cardiovascular surgical devices industry. While some cardiovascular systems are considered urgent, others have been postponed and delayed since the beginning of the global pandemic. Another factor negatively affecting the cardiovascular surgical devices market is reducing the diagnosis of cardiovascular diseases due to healthcare resources being reserved for COVID-19 patients.

 

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/cardiovascular-surgical-device-market-p.php

 

Cardiovascular Surgical Devices Market: Key Players

The global cardiovascular surgical devices sector is highly fragmented, with many players such as Abbott Laboratories, Boston Scientific Corporation, Edwards Life sciences, Cardinal Health Inc., Medtronic PLC, and GE Healthcare. Thus, global players are adopting mergers, acquisitions, and collaborations to expand their product offerings and customer base, expanding their market share. For instance, in 2020, Abbott announced the launch of its clip-delivery system to treat patients suffering from mitral regurgitation.

 

Market Summary:

Type – We have covered Global Cardiovascular Surgery Devices Market breakup by 4 viewpoints by Type (Perfusion Disposables, Cardiopulmonary Bypass Equipment, Beating Heart Surgery Treatment and Ventricular Assist Device)

Application – This Report has covered Market breakup by 4 viewpoints (Interventional Cardiac Surgery, Cardiac Rhythm Management, Traditional Cardiac Surgery and Others)

End User - Renub Research Report covered in the 3 viewpoints (Hospitals, Cardiac Diagnostic Centres and Ambulatory Surgical Centre)

Regions – Our Report covers Global Cardiovascular Surgery Devices Market breakup by 4 Regions (North America, Europe, Asia Pacific and ROW)

All the major companies have been covered from 3 Viewpoints (Recent Development, Overview, and Revenue Analysis) Abbott Laboratories, Boston Scientific Corporation, Edwards Life sciences, Cardinal Health Inc., Medtronic PLC and GE Healthcare.

 

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

 

Contact Us:

Renub Research

Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)

Email: info@renub.com

Web: https://www.renub.com

Follow on Linkedin: https://www.linkedin.com/company/renub-research

Follow on Twitter: @renubresearch